Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Non-Performing Assets / Total Loans data is not available.
Income Statement Financials | |
-- |
|
$-3.32M |
|
-- |
|
-- |
|
$3.49M |
|
$-3.49M |
|
$0.16M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.49M |
|
$-3.49M |
|
22.81M |
|
22.81M |
|
$-0.14 |
|
$-0.14 |
|
Balance Sheet Financials | |
$11.98M |
|
$0.24M |
|
$0.84M |
|
$12.82M |
|
$2.25M |
|
-- |
|
$0.18M |
|
$2.43M |
|
$10.39M |
|
$10.39M |
|
$10.39M |
|
18.86M |
|
Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
5.33 |
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.97% |
|
-31.97% |
|
-25.92% |
|
-31.97% |
|
$0.55 |
|
-- |
|
-- |